Trimethylamine-N-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body
Introduction This study reviews the different steps involved in trimethylamine-N-oxide (TMAO) formation, a gut microbiota (GM)-derived compound that promotes cardiovascular and chronic kidney disease. The formation of TMAO is a metaorganismal process, where trimethylamine (TMA), produced from the di...
Saved in:
Main Authors: | Ylenia Heinrich-Sanchez, Marius Vital |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2525403 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential
by: I. N. Grigorieva
Published: (2022-09-01) -
TMAO metaorganismal pathway and chronic inflammatory diseases
by: Zeneng Wang, et al.
Published: (2025-06-01) -
Effects of choline metabolite—trimethylamine N-oxide on immunometabolism in inflammatory bowel disease
by: Siyu Wang, et al.
Published: (2025-07-01) -
Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease
by: E. A. Kashukh, et al.
Published: (2019-09-01) -
Interactions between traditional chinese medicine and gut microbiota in chronic diseases
by: Lei Chen, et al.
Published: (2025-09-01)